On Nov. 10, 2015, Mr. Huber lost his wife to colon cancer. He is now going to be the CEO of the startup Grail, which will focus on the development of an early detection blood test for cancer.
The company, created by genetic variation and biological function analysis company Illumina, is backed by funding from its founder, Sutter Hill Ventures, ARCH Ventures, Bezos Expeditions and Bill Gates, according to the report.
Grail has already raised $100 million.
More articles on health IT:
The CIO’s role in cost improvement
Federal government seeking first-ever CISO
Walgreens introduces drug disposal kiosks at 500 stores
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.